Skip to Content

Diadexus Inc DDXSQ

Rating as of

Morningstar’s Analysis

Currency in
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Diadexus Inc is a United States based diagnostics company. It develops and commercializes products that deliver healthcare providers with relevant information to assist in the management of their patients throughout the course of a cardiac disease. Its products include test kits for diagnosis of cardiovascular disease, liver disease, cancer markers, renal disease, diabetes, and electrolytes. Geographically the business presence of the firm is seen in the regions of US, Europe and rest of the world of which US region accounts for the majority of revenue.

349 Oyster Point Boulevard
South San Francisco, CA, 94080-1913
T +1 650 246-6400
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings Mar 31, 2016
Fiscal Year End Dec 31, 2016
Stock Type Distressed
Employees 38